EUVIMEDEUVIMED entdecken
Crossref

Metastasis Profile and Survival Outcomes of Metastatic Non-Muscle Invasive Bladder Cancer: A National Cancer Database Analysis

Mohamed Javid Raja Iyub, Pushan Prabhakar, Deerush Kannan Sakthivel, Aditi Chandrasekaran, Manuel Ozambela, Murugesan Manoharan

Clinical Genitourinary Cancer · 2026-02 · 24 (1) · 102462

DOI: 10.1016/j.clgc.2025.102462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genitourinary Cancer, 2026-02. Verfasst von Mohamed Javid Raja Iyub und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urologic Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL. Electronic address: mohamedjavid.rajaiyub@baptisthe…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Lung Neoplasms, Bone Neoplasms, Liver Neoplasms. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Metastatic non-muscle invasive bladder cancer (mNMIBC) is a condition in which bladder cancer patients develop metastasis in the absence of muscle invasion. The nature of mNMIBC is understudied due to its recent increased recognition. The study aimed to analyze the baseline characteristics, metastatic patterns, and survival outcomes of this condition. METHODS: A retrospective analysis of the National Cancer Database (NCDB) (2004-2021) was done to identify NMIBC patients who presented with distant metastasis at diagnosis, as defined in the NCDB. The patient characteristics, metastatic trends, and survival outcomes were analyzed. Multivariable logistic regression was performed to identify the variables associated with mNMIBC. Cox proportional hazards regression and Kaplan-Meier analysis were used to analyze the survival outcomes (overall survival). RESULTS: Among the 537,674 patients diagnosed with NMIBC, 3982 (0.74%) patients had metastasis. The most common sites of metastasis were the bone (15.3%), followed by the lung (13.6%), liver (7.1%), and brain (0.9%). Furthermore, 15.1% of patients had multiple metastases. The median overall survival (OS) for mNMIBC was 6.54 months (95% Confidence Interval [CI]: 6.04-7.03). The OS was poorer among patients with metastasis to multiple sites (median OS: 3.55 months; 95% CI, 3.05-4.04) compared to those with metastasis to a single site. The best OS in isolated metastasis was seen in lung metastasis (median OS: 8.48 months; 95% CI, 6.68-10.27), and the worst OS was seen in liver metastasis (median OS: 3.70 months; 95% CI, 2.80-4.56). Older age, higher Charlson comorbidity score, and non-urothelial histology were associated with worse OS (P < .05). CONCLUSION: mNMIBC is an uncommon condition with poor OS. Metastases to multiple sites have a poorer prognosis than metastases to a single site. Among the single-site metastases, the most common metastatic site was bone, and the best OS was seen in lung metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsLung NeoplasmsBone NeoplasmsLiver NeoplasmsBrain NeoplasmsHumansMaleFemaleAgedRetrospective StudiesMiddle AgedDatabases, FactualPrognosisNeoplasm InvasivenessUnited StatesAged, 80 and overKaplan-Meier EstimateSurvival RateNeoplasm MetastasisNon-Muscle Invasive Bladder Neoplasms

Stichwörter der Autor:innen

Metastatic NMIBCMetastatic bladder cancerNMIBCNMIBC with metastasisUrothelial cancer

Autor:innen und Institutionen

  • Department of Urologic Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL. Electronic address: mohamedjavid.rajaiyub@baptisthealth.net.
  • Department of Urologic Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL.
  • Department of Urologic Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL; Department of Urology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL.

Zitieren

APA

Raja Iyub, M. J., Prabhakar, P., Sakthivel, D. K., Chandrasekaran, A., Ozambela, M., & Manoharan, M. (2026). Metastasis Profile and Survival Outcomes of Metastatic Non-Muscle Invasive Bladder Cancer: A National Cancer Database Analysis. Clinical Genitourinary Cancer, 24(1), 102462. https://doi.org/10.1016/j.clgc.2025.102462

Vancouver

Raja Iyub MJ, Prabhakar P, Sakthivel DK, Chandrasekaran A, Ozambela M, Manoharan M. Metastasis Profile and Survival Outcomes of Metastatic Non-Muscle Invasive Bladder Cancer: A National Cancer Database Analysis. Clinical Genitourinary Cancer. 2026;24(1):102462. doi:10.1016/j.clgc.2025.102462

BibTeX
@article{RajaIyub2026,
  author = {Raja Iyub, Mohamed Javid and Prabhakar, Pushan and Sakthivel, Deerush Kannan and Chandrasekaran, Aditi and Ozambela, Manuel and Manoharan, Murugesan},
  title = {Metastasis Profile and Survival Outcomes of Metastatic Non-Muscle Invasive Bladder Cancer: A National Cancer Database Analysis},
  journal = {Clinical Genitourinary Cancer},
  year = {2026},
  volume = {24},
  number = {1},
  pages = {102462},
  doi = {10.1016/j.clgc.2025.102462}
}
Kostenlos starten →